2010
DOI: 10.1111/j.1601-183x.2009.00532.x
|View full text |Cite
|
Sign up to set email alerts
|

The effect of mGlu8 deficiency in animal models of psychiatric diseases

Abstract: The metabotropic glutamate receptor subtype 8 (mGlu 8 ) is presynaptically located and regulates the release of the transmitter. Dysfunctions of this mechanism are involved in the pathophysiology of different psychiatric disorders. mGlu 8 deficient mice have been previously investigated in a range of studies, but the results are contradictory and there are still many open questions. Therefore, we tested mGlu 8 -deficient animals in different behavioral tasks that are commonly used in neuropsychiatric research.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
24
1

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 41 publications
(26 citation statements)
references
References 52 publications
(138 reference statements)
1
24
1
Order By: Relevance
“…Despite this caveat, there is still much evidence to suggest that AMN082 elicits its effect through a glutamatergic mechanism as the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione attenuated the antidepressant-like effects of AMN082 (Bradley et al, 2011), MMPIP attenuated the antidepressant-like effect of AMN082 in rats (PaluchaPoniewiera and Pilc, 2012), and the influence of AMN082 on freezing behaviour has been shown to be mediated through nonmonoaminergic mechanisms (Toth et al, 2012). Furthermore, data collected through both pharmacological modulation and genetic ablation of the mGlu 7 receptor are in agreement with this proposition (Siegl et al, 2008;Fendt et al, 2010;Bahi et al, 2012). There is also evidence indicating that MMPIP can block the behavioural effects of AMN082 (Li et al, 2010;Bahi et al, 2012).…”
Section: Discussionsupporting
confidence: 55%
“…Despite this caveat, there is still much evidence to suggest that AMN082 elicits its effect through a glutamatergic mechanism as the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione attenuated the antidepressant-like effects of AMN082 (Bradley et al, 2011), MMPIP attenuated the antidepressant-like effect of AMN082 in rats (PaluchaPoniewiera and Pilc, 2012), and the influence of AMN082 on freezing behaviour has been shown to be mediated through nonmonoaminergic mechanisms (Toth et al, 2012). Furthermore, data collected through both pharmacological modulation and genetic ablation of the mGlu 7 receptor are in agreement with this proposition (Siegl et al, 2008;Fendt et al, 2010;Bahi et al, 2012). There is also evidence indicating that MMPIP can block the behavioural effects of AMN082 (Li et al, 2010;Bahi et al, 2012).…”
Section: Discussionsupporting
confidence: 55%
“…Consistent with a role for mGluR8 in the regulation of anxiety, increased measures of anxiety in the open field and the elevated plus maze, and an increased acoustic startle response were seen in 6- and 12-month-old mGluR8 −/− male mice [79]. These effects seem age-dependent as no genotype differences were seen in the elevated plus maze or elevated zero maze in 3-month-old mice [10]. While potential effects of mGluR8 deficiency in utero , during postnatal development, or during early adulthood might have contributed to the observed behavioral phenotype, they do not seem required for the anxiety modulating effects.…”
Section: Introductionmentioning
confidence: 77%
“…While there have been mixed reports about the effect of mGluR agonists on fear conditioning, in general, mGluR antagonists and genetic deletion of mGluRs in the limbic regions of the brain appear to impair both consolidation and extinction of fear conditioning 125130 . Activation of mGluR1-containing receptors in the BLA is known to enhance fear learning 131 .…”
Section: Glutamatergic Signaling In Fear Conditioningmentioning
confidence: 99%